Camp4 Therapeutics (CAMP)Director bought ~$131K

~$131K

Approx. value · 85K sh @ $1.53

198K

Holds after · shares reported

Traded

Sep 11, 2025

Filed

Sep 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 9, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesChanged a top executive or board member, and signed an important agreement (and 2 more items)“On September 9, 2025, each of James Boylan, Ravi Thadhani, M.D., and Paula Ragan, Ph.D. notified the Company’s board of directors (the “ Board ”) of their resignation as members of the Board, in each case, effective on that same date.”
2. Sep 11, 2025 · this disclosureInsiderDirector purchased ~$131K of CAMP shares in the open market

What came next

1. Sep 11, 2025Insider · 7 peopleInsiders: 8 purchases (~$8.4M)
2. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
3. Dec 17, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
4. Dec 18, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
5. Dec 22, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Camp4 Therapeutics

For Camp4 Therapeutics, OQRO holds 11 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CAMP page.

Other recent filings by Amir Nashat, Director

• SEC Form 4 at Camp4 Therapeutics (CAMP)Sep 11, 2025
• SEC Form 4 at Camp4 Therapeutics (CAMP)Oct 15, 2024

The full history of Amir Nashat, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Camp4 Therapeutics

• SEC Form 4Sep 2, 2026
• SEC Form 4Aug 31, 2026
• SEC Form 4Aug 26, 2026
• SEC Form 4Aug 21, 2026
• SEC Form 4Aug 21, 2026
• SEC Form 4Aug 21, 2026

Everything OQRO holds on this company is on its CAMP page.